Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

AstraZeneca Groomed Paul Hudson For His New Role … At Novartis

Executive Summary

Ten years at AstraZeneca PLC have prepared US President and Executive Vice President of North America Paul Hudson for his next C-suite job, but unfortunately for his current employer that gig is with a major competitor – Novartis AG.


Related Content

2Q Pharma Results Preview: What Lies Ahead
Panel: Pricing Dilemma Divides Industry Stakeholders
Novartis's Entresto Doesn't Impress In 1Q; Orphan Drug Fails In PhIII
Novartis To Payers: Entresto Works Or You Get A Discount
AZ's Brilinta Takes Next Step, Gains FDA Approval For Extended Use
ACC 2015: AstraZeneca optimistic on Brilinta after PEGASUS, others less so
JP MORGAN 2015: AstraZeneca US president on sales and reimbursement
Soriot sharpens broom in AstraZeneca C-suite sweep


Related Companies